Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) is the most common kidney malignancy characterized by a poor prognosis. The treatment efficacy of immune checkpoint inhibitors (ICIs) also varies widely in advanced ccRCC. We aim to construct a robust gene signature to improve the prognostic discrimination and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Xiaomao, Wang, Zaoyu, Wang, Jianfeng, Xu, Yunze, Kong, Wen, Zhang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253123/
https://www.ncbi.nlm.nih.gov/pubmed/34262797
http://dx.doi.org/10.1080/2162402X.2021.1933332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253123/
https://www.ncbi.nlm.nih.gov/pubmed/34262797
http://dx.doi.org/10.1080/2162402X.2021.1933332

Ejemplares similares